diff options
Diffstat (limited to 'Finance/Tickers/CRMD.md')
| -rw-r--r-- | Finance/Tickers/CRMD.md | 23 |
1 files changed, 23 insertions, 0 deletions
diff --git a/Finance/Tickers/CRMD.md b/Finance/Tickers/CRMD.md new file mode 100644 index 0000000..139b726 --- /dev/null +++ b/Finance/Tickers/CRMD.md @@ -0,0 +1,23 @@ +# CorMedix inc. - NASDAQ:CRMD + +Story parrallel to suganmadex introduction + +Taurolock & Taurolidine + +Solving CRBST (catherer blood stream infection) + +CRMD instead of using Citrate develloped their own solution. +Pairing Taurolidine with heparin making DefenCath +DefenCath FDA approved in Nov 2023 +Target: Hospitals & dyalisis clinics + +Total Market potential more or less ~170,000 patient +now around ~3000 patient +already signed contracts for 70% TAM (?) + +looking at end 2027$ + +~250$ per vial +CRBST cost around 63,000$ per case, nothing compared to 250$ + +NTAP end Nov 2026 |